← Every applicant
Umedica FDA Approvals
8 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| RANOLAZINENew drugAug 5, 2026TABLET, EXTENDED RELEASE, ORAL |
| SACUBITRIL AND VALSARTANNew drugAug 4, 2026TABLET, ORAL |
| SERTRALINE HYDROCHLORIDENew drugJan 20, 2026CAPSULE, ORAL |
| VARENICLINE TARTRATENew drugJan 9, 2026TABLET, ORAL |
| DICLOFENAC SODIUMNew drugNov 5, 2025TABLET, DELAYED RELEASE, ORAL |
| DICLOFENAC POTASSIUMNew drugAug 29, 2025FOR SOLUTION, ORAL |
| CARBAMAZEPINENew drugAug 18, 2022TABLET, EXTENDED RELEASE, ORAL |
| DICLOFENAC POTASSIUMNew drugMay 11, 2022TABLET, ORAL |